Why Agenus Stock Is Popping Today
An off-the-shelf cell therapy for COVID-19 is sending the biotech's shares higher today.
Agenus(AGEN)
Nasdaq Capital Market (Nasdaq)
AGEN
$4.00
-$0.09
-2.2%
Price as of February 26, 2021, 9:00 p.m. EST
View Interactive AGEN Charts
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
Interactive Chart
News & Analysis: Agenus
The Fool has written over 100 articles on Agenus.
Agenus Inc (AGEN) Q3 2020 Earnings Call Transcript
AGEN earnings call for the period ending September 30, 2020.
Why Agenus Is Soaring 23.6% Today
Investor optimism is increasing ahead of an oral presentation at ESMO 2020.
Agenus Inc (AGEN) Q2 2020 Earnings Call Transcript
AGEN earnings call for the period ending June 30, 2020.
Here's Why Agenus Stock Jumped Higher Today
The development-stage biopharma delivered two encouraging updates.
Why Agenus Stock Took Flight in May
The immunotherapy company may be a diamond in the rough.
Here's Why Agenus Rose as Much as 23.3% Today
The biopharma company provided a clinical update for an important pipeline asset.
Agenus Inc (AGEN) Q1 2020 Earnings Call Transcript
AGEN earnings call for the period ending March 31, 2020.
3 Top Stocks Under $5 to Buy Now
Agenus, Dynavax Technologies, and Verastem Oncology could all be outstanding picks for risk-tolerant investors.
Top Pharma Stocks Under $5
These clinical-stage drugmakers could be a steal at current levels.
